Back to search

Democritus University of Thrace (DUTH)

Η αλληλεπίδραση μεταβιβαστών φλεγμονής και υποεπιθηλιακών μυοϊνοβλαστών στην ινωτική διεργασία των ιδοπαθών φλεγμονωδών εντεροπαθειών ως στόχος νέων θεραπευτικών στρατηγικών

Abstract

dc:description

Introduction - Inflammatory Bowel Diseases (IBDs), Crohn’s Disease (CD) and Ulcerative Colitis (UC), are characterized by chronic inflammation of the gastrointestinal tract, with unknown etiopathogenesis and immunologic mechanisms involved. Transmural fibrosis development is one of the main characteristics of CD and it is characterized by an increased production of inflammatory and pro-fibrotic mediators that ultimately lead to the activation, proliferation and differentiation of intestinal fibroblasts to myofibroblasts, as well as infiltration of myofibroblasts of different origin. The etiopathogenesis of fibrosis is mostly unknown, but the current literature suggests that innate (TL1A) and adaptive (Th1, Th2, Th17 and Treg) immune responses play a significant role in intestinal fibrogenesis. Tumor necrosis factor (TNF)-like cytokine 1A (TL1A) is a member of TNF’s superfamily, binds to the receptors, DR3 and DcR3 and so far, there is enough evidence suggesting that both TL1A and its receptors are implicated in IBD. Pro-inflammatory mediators of the innate or adaptive immunity induce pro-fibrotic effects on myofibroblasts, driving them towards a fibrotic phenotype. In particular, Th2- and Th17- related cytokines, such as IL-13 and IL-17, respectively, induce mostly pro-fibrotic effects, whereas, Th1- related cytokines, such as IFN-γ, promote mostly anti-fibrotic effects. The expression of TL1A and its receptors, DR3 and DcR3, in colonic subepithelial myofibroblasts (cSEMFs) and in colonic epithelial cells HT-29, as well as the effect of immune responses, Th1, Th2, Th17 and Treg, in cSEMFs’ biologic activity and fibrosis, are poorly studied. Therefore, it would be of interest to investigate the effect of inflammatory mediators in these cells’ physiology and in fibrogenesis. Aim and Objectives - The aim of the present PhD thesis was to study the role and implication of cSEMFs in the inflammatory process, which characterizes IBD, and leads to the onset of fibrosis. For this purpose, we studied the pathogenetic mechanisms involved in the fibrotic process and their regulatory factors, which could serve as new pharmacological targets.In particular, during the first part of the current PhD thesis, one of our objectives was to study the expression of TL1A and its receptors, DR3 and DcR3, in primary human cSEMFs from healthy controls, under inflammatory conditions that resemble IBD and in primary human cSEMFs from patients with CD. In addition, we investigated whether colonic epithelial cells HT-29 express the receptors DR3 and DcR3, under inflammatory conditions and whether there is a crosstalk between HT-29 cells and cSEMFs. During the second part, one of our objectives was to perform an expression mapping of all interleukin receptors, implicated in IBD, in primary human cSEMFs, and to examine the way that pro-inflammatory cytokines of innate immunity, as well as Lipopolysaccharide (LPS) alter this expression. In addition, we studied the effect of adaptive immune responses (Th1, Th2, Th17 and Treg) in the expression of pro-fibrotic factors by cSEMFs, as well as, in their migratory capacity. The ultimate goal of the present PhD thesis was to better understand the etiopathogenetic mechanisms implicated in intestinal fibrosis, and to highlight possible new pharmacological targets that will be part of novel and effective therapeutic strategies for the treatment of intestinal fibrosis. Materials and Methods - In order to achieve our aims, we initially isolated cSEMFs from colonic biopsies obtained from healthy individuals and patients with CD. We also cultured the cell lines, HT-29 and 18CO, which are colonic epithelial cells and colonic embryonic fibroblasts, respectively. Regarding the first part of the present PhD thesis, we first stimulated cSEMFs and 18CO with IL-1α and/or TNF-α, in order to study the mRNA and protein expression of TL1A and its receptors, DR3 and DcR3. Next, we stimulated HT-29 cells with IL-1α, TNF-α and IFN-γ, cultured tissue biopsies from patients with CD and their supernatants were used as stimuli in cSEMFs for the study of mRNA and protein expression of TL1A and its receptors, DR3 and DcR3. We also studied the mRNA and protein expression of TL1A and its receptors, DR3 and DcR3 in cSEMFs from patients with CD. Next, HT-29 cells were stimulated with IL-1α, TNF-α and IFN-γ, in order to investigate the mRNA and protein expression of DR3 and DcR3 receptors. Finally, we stimulated HT-29 cells with TL1A and we examined its effect in the induction of IL-8 mRNA expression.Regarding the second part, we initially stimulated cSEMFs with IL-1α and/or TNF-α, as well as with LPS, in order to investigate the basal and the pro-inflammatory cytokine-induced mRNA and protein expression of interleukin receptors. Next, cSEMFs were stimulated with Th1- (TNF-α and/or IFN-γ), Th2- (IL-4 and/or IL-13), Th17- (IL-17 and/or IL-22 and/or IL-23) and Treg- (IL-10 ad/or TGF-β) related cytokines, in order to investigate the mRNA expression of pro-fibrotic factors, collagen type I and III, fibronectin, α-SMA, TF, metalloproteinase-1 (MMP-1), MMP-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 and the protein expression of collagen and fibronectin. Finally, we stimulated cSEMFs with Th1- (TNF-α and/or IFN-γ), Th2- (IL-4 and/or IL-13), Th17- (IL-17 and/or IL-22 and/or IL-23) and Treg- (IL-10 ad/or TGF-β) related cytokines, in order to examine their effect in cSEMFs’ migratory capacity via scratch test assay. During the mRNA expression studies, total RNA was isolated from cultured cells, cDNA synthesis was performed and the real time rt-PCR method was used for the detection of mRNA expression levels. Protein expression studies were performed using either immunofluorescence, or the ELISA method. Collagen protein levels were measured using the Sircol method. Statistical analysis was performed with Student's t test. Results - Regarding the first part, cSEMFs and 18CO cells stimulated with the pro-inflammatory cytokines IL-1α and/or TNF-α, abundant in the inflamed intestinal mucosa of patients with IBD, expressed upregulated levels of TL1A mRNA and protein expression. Tissue supernatants from cultured biopsies of patients with CD induced the TL1A mRNA and protein expression in cSEMFs. cSEMFs isolated from patients with CD were found to express TL1A. Stimulated HT-29 cells with IL-1α, TNF-α and IFN-γ expressed upregulated mRNA and protein levels of DR3 receptor, and their supernatants induced the mRNA and protein expression of TL1A in cSEMFs. HT-29 cells stimulated with TL1A expressed upregulated mRNA levels of IL-8. Regarding the second part, a basal expression of interleukin receptors (Τh1: IFNGR1, IFNGR2, TNFRSF1A, IL12RB2, IL1R1 and IL1R2, Th2: IL4R and IL13RA2, Th17: IL22RA1, Treg: IL10RA, IL10RB, TGFBR1 and TGFBR2) was found in cSEMFs isolated from healthy individuals. Stimulation of cSEMFs with pro-inflammatory cytokines IL-1α and/or TNF-α had a positive or negative effect in interleukin receptor expression patterns. LPS stimulation did not cause any statistically significant upregulation or downregulation of interleukin receptors expression. cSEMFs stimulated with Th1- related cytokines expressed upregulated mRNA levels of TF and MMP-1, upregulated protein levels of collagen and fibronectin and reduced mRNA levels of α-SMA, MMP-9 and migration rate. Th2- related cytokines induced an upregulation of mRNA collagen, TF, α-SMA and MMP-1 expression and migration rate in cSEMFs and a downregulation of fibronectin protein and MMP-9 mRNA expression. Th17- related cytokines had a mixed effect in cSEMFs; IL-17 and IL-23 induced an upregulation of fibronectin expression, whereas IL-22 stimulation resulted in reduced fibronectin and TF expression. Similar results were obtained from scratch test assay; IL-17 and IL-22 reduced migratory rate, whereas IL-23 enhanced it. Additionally, IL-23 induced the mRNA expression of both MMP-1 and TIMP-1. Finally and as expected, TGF-β proved to be the most potent pro-fibrotic factor, as it upregulated all studied pro-fibrotic mediators, as well as migratory capacity of cSEMFs. Conclusions - In the present PhD thesis, we concluded that cSEMFs are directly implicated in intestinal inflammation and that innate and adaptive immune responses have a significant role in the development of intestinal fibrosis. Additionally, the current PhD thesis highlights new possible pharmacological targets, whose further study may lead to the development of novel and effective therapeutic strategies for the treatment of intestinal fibrosis.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Filidou, Eirini
  • Φιλίδου, Ειρήνη

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43506

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Filidou, Eirini; Φιλίδου, Ειρήνη. Η αλληλεπίδραση μεταβιβαστών φλεγμονής και υποεπιθηλιακών μυοϊνοβλαστών στην ινωτική διεργασία των ιδοπαθών φλεγμονωδών εντεροπαθειών ως στόχος νέων θεραπευτικών στρατηγικών. Democritus University of Thrace (DUTH), 2018. http://hdl.handle.net/10442/hedi/43506